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Abstract
Background: Cu/Zn-superoxide dismutase 1 (SOD1), encoded on chromosome 21, is a key
enzyme in the metabolism of reactive oxygen species (ROS) and pathogenetically relevant for
several disease states including Down syndrome (DS; trisomy 21). Systematically studying protein
expression in human brain and animal models of DS we decided to carry out "protein hunting" for
hypothetical proteins, i.e. proteins that have been predicted based upon nucleic sequences only, in
a transgenic mouse model overexpressing human SOD1.
Results: We applied a proteomics approach using two-dimensional electrophoresis (2-DE) with
in-gel digestion of spots followed by mass spectrometric (matrix-assisted laser desorption/
ionization-time of flight) identification and quantification of hypothetical proteins using specific
software. Hippocampi of wild type, hemizygous and homozygous SOD1 transgenic mice (SOD1-
TGs) were analysed.
We identified fourteen hypothetical proteins in mouse hippocampus. Of these, expression levels
of 2610008O03Rik protein (Q9D0K2) and 4632432E04Rik protein (Q9D358) were significantly
decreased (P < 0.05 and 0.001) and hypothetical protein (Q99KP6) was significantly increased (P <
0.05) in hippocampus of SOD1-TGs as compared with non-transgenic mice.
Conclusions: The biological meaning of aberrant expression of these proteins may be impairment
of metabolism, signaling and transcription machinery in SOD1-TGs brain that in turn may help to
explain deterioration of these systems in DS brain.
Background
A large body of evidence proposes the involvement of
reactive oxygen species (ROS), such as superoxide anion,
hydrogen peroxide and hydroxyl radical in the generation
of oxidative stress in a broad range of neuropathology [1-
4]. Under normal physiological conditions, there is equi-
librium between oxidant and antioxidant mechanisms
but their imbalance results in ROS formation, leading to
oxidative stress – mediated cellular damage [5,6]. The
molecular mechanisms by which altered concentrations
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of ROS influence cellular functions are not fully
elucidated.
The enzyme Cu/Zn-superoxide dismutase 1 (SOD1;
E.C.1.15.1.1), which catalyses the conversion of superox-
ide radicals into the less toxic hydrogen peroxide (H2O2)
plays an important role in the metabolism of ROS [7]. It
is a homodimer, encoded on chromosome 21 and has
been suggested to be involved in the pathogenesis of neu-
rological disease including familial amyotrophic lateral
sclerosis, a degenerative disorder of motor neurons in cor-
tex, brainstem and spinal cord [3] and probably in Down
syndrome (DS) [8]. A transgenic mouse overexpressing
human SOD1 was created and may serve as a model for
neurodegenerative disorders [9]. It has been reported that
hippocampal slices from transgenic mice overexpressing
SOD1 (SOD1-TG) were found to exhibit deficient long-
term potentiation, a putative neural substrate of memory,
and hippocampal-mediated memory function [10]. We
decided to use a proteomic approach carring out protein
profiling in hippocampus and to perform "protein hunt-
ing" using two-dimensional gel electrophoresis (2-DE)
with subsequent matrix-assisted laser desorption/ionisa-
tion-time of flight (MALDI-TOF) identification of brain
proteins followed by quantification using specific soft-
ware, which represents a powerful tool in neurosciences
[11-20]. The aim of this study was to search for the exist-
ence of hypothetical proteins (HPs), that have been iden-
tified based upon their nucleic acid sequences only and
resulted in the detection of 14 HPs and significant expres-
sional differences of HPs related to metabolism, signaling
and the transcriptional machinery were observed in hip-
pocampus of the SOD1-TG. This maybe helpful for under-
standing the role of SOD1 in neurodegenerative
disorders.
Results
Increased activity of SOD1 in SOD1-TG mice
Overexpression of SOD1 was evaluated by enzymatic
activity using the classic test of inhibition of nitroblue
tetrazolium reduction by SOD1 and automatically
assayed using a Ransod kit. The SOD1 activity was
increased by factor 5 in blood. Measurements throughout
the central nervous system (CNS) showed large increases
in total SOD1 activity: hemizygous and homozygous
SOD1-TG mice revealed an increase of 9.4 and 13.8
respectively in SOD1 specific activities as compared to WT
(Unpublished data). In SOD1-TG mice, immunostaining
for human SOD1 was strong in the brain and no immu-
nostaining occurred in the CNS of WT, indicating that
labeling was specific for human SOD1 [9].
2-DE analysis
Hippocampal proteins were solubilized in the IEF-com-
patible reagents urea, thiourea and CHAPS and analysed
by 2-D gels. The 2-DE separation was performed on broad
pH range IPG strips and protein spots were visualized fol-
lowing staining with colloidal Coomassie blue. A series of
HPs were successfully identified and a representative gel is
shown in Fig. 1.
Protein identification
Proteins were identified by MALDI-TOF on the basis of
peptide mass matching [21] following in-gel digestion
with trypsin. Spots of each gel were selected randomly
with the goal of detecting as many new gene products as
possible ("protein hunting"). The peptide masses were
matched with the theoretical peptide masses from mouse
and, if not successful, of all known proteins from all spe-
cies. In total about 700 spots were analysed, resulting in
the identification of about 300 polypeptides that were the
products of 153 different genes (Unpublished data, Shin
et al., 2003). Fourteen of 153 gene products were hypo-
thetical or poorly described gene products. Most HPs were
represented by strong spots and the present study shows
that they are indeed expressed in mouse hippocampus. In
Table 1, data for hypothetical protein identification and
assignment are provided including peptide matches, score
(probability of assignment of random identity, http://
www.matrixscience.com), theoretical/observed pI  and
molecular weight values. Similar to mitochondrial aconi-
tase (Q99KI0) showed heterogeneity and was represented
by three spots, with different pI, probably reflecting post-
translational modifications (PTMs) (Fig. 1).
Grouping of HPs by predicted function
Classification of HPs on the basis of sequence homology
is based on the assumption that related proteins will have
similar function. Sequence-to-function approach is the
most commonly used method for functional prediction
and well developed. In this study, sequence-motif
approach (Pfam, Pfam protein domain database, http://
www.sanger.ac.uk/Pfam/) and NCBI database was used
for searching conserved domains and identity to function-
known protein by sequence similarity (Conserved
Domain Database, http://www.ncbi.nlm.nih.gov/BLAST)
(Table 1). A HP showing one or more significant struc-
tural homologues is predicted to have molecular and
functional properties similar to the homologues. Hypo-
thetical proteins were divided into several groups by puta-
tive function (Table 1). Putative cellular localizations of
hypothetical proteins were investigated by PSORT II using
of k-nearest neighbor (k-NN) algorithm for assessing the
probability of localizing at each candidate sites http://
www.psort.org. Hypothetical proteins may be localized in
cytoplasm (8 of 14, 57.1 %), mitochondria (4 of 14, 28.6
%) and nuclear (2 of 14, 14.3 %) (Table 1).Proteome Science 2004, 2 http://www.proteomesci.com/content/2/1/2
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2-DE gel image of mouse hippocampus proteins depicting identified fourteen hypothetical proteins Figure 1
2-DE gel image of mouse hippocampus proteins depicting identified fourteen hypothetical proteins. Accession numbers are 
given. Brain proteins were extracted and separated on an immobilized pH 3–10 non-linear gradient strip followed by separa-
tion on a 9–16% gradient polyacrylamide gel. The gel was stained with Coomassie blue and spots were analyzed by MALDI-
TOF.
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Quantitative variation of hypothetical proteins in SOD1-
TG mice
2610008O03Rik protein (Q9D0K2) was detected in 2-DE
gels as one spot (Fig. 1) and expression level of
2610008O03Rik protein was significantly decreased in
homozygous SOD1-TG as compared to wild types (P <
0.05).
Expression of 4632432E04Rik protein (Q9D358) showed
a significant decrease in both, hemizygous and
homozygous SOD1-TGs (P < 0.05; P < 0.001).
Hypothetical protein (Q99KP6) was detected in 2-DE gels
as one spot and expression level of this protein was signif-
icantly increased in hippocampus of hemizygous and
homozygous SOD1-TG (P < 0.05) (Table 2). This HP has
Table 1: Identification of fourteen hypothetical proteins in mouse hippocampus and their putative functions
Theoretical/Observed
Accession-
number
Protein name Putative functionb / 
localization
BLAST 
Alignment 
(identity to, %)
Matches 
(Score)c
pI MW (kDa)
Metabolism-related proteins
O54983 Mu-crystallin homolog Ornithine 
cyclodeaminase / 
cytoplasm
Q9QYU4 (97%) 14 (124) 5.44 / 5.55 33.52 / 34.20
Q99KI0 Similar to mitochondrial 
aconitase
Aconitase / cytoplasm or 
mitochondria
Q9ER34 (97%) 18 (122) 8.08 /7.80–8.00 85. 46 / 85.40
Q9CWS0 2410006N07Rik protein Amidinotransferase / 
cytoplasm
O08557 (98%) 23 (199) 5.64 / 5.65 31.38 / 35.20
Q9CXN1 3110052N05Rik protein Sugar phosphatase / 
cytoplasm
Q9H008 (38%) 11 (133) 5.70 / 5.73 28.73 / 28.50
Q9D051 2610103L06Rik protein Pyruvate dehydrogenase 
E1, beta subunit / 
mitochondria
P11177 (93%) 12 (66) 6.41 / 5.58 38.94 / 32.20
Q9D0K2a 2610008O03Rik protein Succinyl-CoA: 3-ketoacid 
transferase / 
mitochondria
P55809 (87%) 9 (68) 8.73 / 7.82 55.99 / 52.10
Q9D2G2 4930529O08Rik protein Dihydrolipoamide 
succinyltransferase / 
mitochondria
P36957 (76%) 15 (116) 9.10 / 5.74 48.99 / 49.20
Signaling-related proteins
Q9D358 4632432E04Rik protein Protein tyrosine 
phosphatase / neclear
Q9QWF5 (99%) 6 (59) 6.13 / 5.72 17.92 / 15.55
Q9D8Y0 Swiprosin 1 Predicted Ca2+-binding 
protein, EF-hand protein 
superfamily / cytoplasm
NH 16 (155) 5.01 / 5.10 26.79 / 30.85
Transcription-related proteins
Q99KP6 Hypothetical protein mRNA splicing factor / 
cytoplasm
9 (75) 6.14 / 6.25 55.24 / 53.00
Q99LX0 Similar to DJ-1 protein Putative transcriptional 
regulator / cytoplasm
O88767 (95%) 18 (156) 6.32 / 6.08 20.02 / 20.85
Others
AAA59434d Germline-encoded VH3 
immunoglobulin binding- 
locus
Immunoglobulin binding / 
cytoplasm
P23083 (96%) 5 (73) 9.43 / 5.32 11.20 / 32.50
Q61786 ORF 1 Transposase / nuclear NH 9 (63) 10.07 / 7.00 32.48 / 49.10
Q9NVA2 Hypothetical protein 
FLJ10849
Cell division-associated 
protein / cytoplasm
Q14141 (80%) 18 (173) 6.36 / 6.40 49.40 / 49.30
Mouse hippocampus proteins were separated by 2-DE and identified by MALDI-TOF, following in-gel digestion with trypsin. The spots representing 
the identified proteins are indicated in Fig 1 and are designated with their accession numbers of SWISS-PROT or dNCBI database. The number of 
matching peptides (Matches), probability of assignment (Score), theoretical molecular weight (MW), and pI values are given. a Identified in rat brain 
(Unpublished data, Shin et al., 2003) bPrediction of function of hypothetical proteins was performed by sequence-motif approach (Pfam, http://
www.sanger.ac.uk/Pfam/) and NCBI database (BLAST search, http://www.ncbi.nlm.nih.gov/BLAST) and putative localization resulted from PSORT II 
http://www.psort.org using of k-nearest neighbour (k-NN) algorithm for assessing the probability of localising at each candidate sites. c Score is – 
10*Log (P), where P is the probability that the observed match is a random event (MASCOT, http://www.matrixscience.com). NH, there was no 
comparable homologs with known functionProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/2
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504 amino acid residues and its nucleic acid sequence was
directly submitted to the EMBL/GenBank/DDBJ database
(Strausberg R., 2001).
Mouse SOD1 was significantly reduced in hemizygous
SOD1-TGs (P  < 0.05) and even more pronounced in
homozygous SOD1-TGs (P < 0.001) (Table 2). Human
SOD1 presented with two spots in the gel and was unde-
tectable in WTs. Spot 1 of human SOD was clearly repre-
sented in hemizygous SOD1-TGs and significantly higher
in homozygous SOD1-TGs (P < 0.05). Spot 2 of human
SOD1 and the sum of both spots were significantly higher
in homozygous than in hemizygous SOD1-TGs (P  <
0.05).
Discussion
We herein describe existence of fourteen HPs in mouse
hippocampus that were predicted based upon their
nucleic acid structure only (Fig. 1 and Table 1). Quantita-
tive evaluation of expression levels revealed that expres-
sion of three HPs was deranged in hemizygous and
homozygous SOD1-TGs: Expression levels of
2610008O03Rik protein (Q9D0K2) and 4632432E04Rik
protein (Q9D358) were significantly decreased in SOD1-
TG hippocampus while Hypothetical protein (Q99KP6)
was significantly decreased (Fig. 2 and Table 2). We fur-
thermore show that human SOD1 is clearly expressed in
homozygous and hemizygous SOD1-TGs at the protein
level.
2610008O03Rik protein (Q9D0K2) has two conserved
domains, coenzyme A (CoA) transferases (pfam01144)
(Fig. 3), and belongs to an evolutionary conserved family
of enzymes catalyzing the reversible transfer of CoA from
one carboxylic acid to another. Predicted function of
2610008O03Rik protein is succinyl-CoA: 3-ketoacid CoA
transferase (SCOT, EC 2.8.3.5) (Table 1), a mitochondrial
enzyme in mammals that is essential for the metabolism
of ketone bodies. SCOT is responsible for the transfer of
coenzyme A (CoA) from succinyl-CoA to acetoacetate. 3-
oxoacid CoA-transferase, which catalyses the first commit-
ted step in the oxidation of ketone bodies, is uniquely
regulated in developing rat brain [22]. Changes in 3-
oxoacid CoA-transferase activity in rat brain during the
postnatal period are due to changes in the relative rate of
synthesis of the enzyme [22]. In addition,
2610008O03Rik protein was detected in 2-DE gel of rat
brain [23]. Although the significance of this enzyme in DS
Table 2: Quantified hypothetical proteins in hippocampus of SOD1-TG and wild types.
Transgenic SOD1 mice
Protein name Wild-type (n = 7) Hemizygous (n = 8) Homozygous (n = 11)
2610008O03Rik protein (Q9D0K2) 1.991 ± 0.318 1.440 ± 0.242 1.343 ± 0.206* S
4632432E04Rik protein (Q9D358) 0.448 ± 0.087 0.433 ± 0.084* 0.287 ± 0.049** S
Hypothetical protein (Q99KP6) 0.351 ± 0.051 0.430 ± 0.055* 0.445 ± 0.084* S
Mouse SOD1 (P08228) 3.584 ± 0.771 2.405 ± 0.289* 2.236 ± 0.419*** S
Human SOD1†(P00441) spot 1 ND 2.296 ± 0.684 3.387 ± 1.289* S
spot 2 ND 9.948 ± 1.741 11.284 ± 1.314* S
sum ND 12.244 ± 2.259 14.671 ± 1.804* S
Mu-crystallin homolog (O54983) 0.708 ± 0.233 0.597 ± 0.197 0.589 ± 0.148 NS
Similar to mitochondrial 
aconitase (Q99KI0)
spot 1 1.169 ± 0.308 1.211 ± 0.283 1.186 ± 0.412 NS
spot 2 1.456 ± 0.260 1.823 ± 0.344 1.515 ± 0.540 NS
spot 3 1.341 ± 0.532 1.959 ± 0.631 1.565 ± 0.476 NS
sum 3.966 ± 0.994 4.992 ± 0.915 4.266 ± 1.305 NS
2410006N07Rik protein (Q9CWS0) 1.031 ± 0.158 1.135 ± 0.244 1.132 ± 0.269 NS
3110052N05Rik protein (Q9CXN1) 0.373 ± 0.078 0.392 ± 0.126 0.380 ± 0.130 NS
2610103L06Rik protein (Q9D051) 2.311 ± 0.865 2.927 ± 0.378 2.986 ± 0.719 NS
4930529O08Rik protein (Q9D2G2) 0.301 ± 0.092 0.315 ± 0.112 0.404 ± 0.103 NS
Swiprosin 1 (Q9D8Y0) 0.636 ± 0.216 0.669 ± 0.263 0.655 ± 0.260 NS
Similar to DJ-1 protein (Q99LX0) 1.167 ± 0.245 1.310 ± 0.119 1.249 ± 0.260 NS
Germline-encoded VH3 immunoglobulin binding- locus 
(AAA59434)
0.458 ± 0.190 0.515 ± 0.146 0.432 ± 0.263 NS
ORF 1 (Q61786) 0.263 ± 0.044 0.323 ± 0.060 0.266 ± 0.062 NS
Hypothetical protein FLJ10849 (Q9NVA2) 0.488 ± 0.070 0.541 ± 0.192 0.506 ± 0.101 NS
Spots were quantified using the 2D Image Master software following selection of an area of interest. Between-group differences were analyzed with 
non-parametric †Mann-Whitney U test or Kruskall-Wallis test. ND, not detected; NS, not significant; S, significant: * P > 0.05; **P > 0.01; ***P > 
0.001Proteome Science 2004, 2 http://www.proteomesci.com/content/2/1/2
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has never been studied, the findings of the derangement
of intermediary metabolism-related enzymes in DS brain
[24] and decreased expression of 2610008O03Rik protein
indirectly suggest involvement of this enzyme system in
brain development or metabolism mechanisms of SOD1-
TG and probably DS.
4632432E04Rik protein (Q9D358) showed high similar-
ity to low molecular weight phosphotyrosine protein
phosphatase (or acid phosphatase) (LMW-PTP) acting on
tyrosine phosphorylated proteins, low-MW aryl-phos-
phates and natural and synthetic acyl-phosphates [25,26].
Reversible phosphorylation on tyrosine residues is a key
process governing cell division, growth and differentia-
tion. This activity is carried out by phosphotyrosyl protein
phosphatases (PTPs) (EC 3.1.3.48) acting as a negative
control of receptor tyrosine kinases (PTKs), which are
important mediators of intracellular signalling [27-29].
The LMW-PTPs are a group of soluble PTPases displaying
a reduced molecular mass. Great attention was recently
focused on LMW-PTPs, a group of cytosolic non-receptor
PTPs, 18-kDa enzymes widely distributed in mammalian
tissues, previously known as low molecular weight acid
phosphatates [30,31]. These enzymes, although
structurally unrelated with the other PTPs, display at the
active site the consensus sequence CXXXXXRS/T typical of
all members of the PTP superfamily [30]. In mammalian
cells, LMW-PTP is able to specifically bind and
The partial images of hypothetical proteins representing aberrant expression in hippocampus of SOD1-TGs (arrow) Figure 2
The partial images of hypothetical proteins representing aberrant expression in hippocampus of SOD1-TGs (arrow). In addi-
tion, spots of mouse SOD1 and human SOD1 were detected in 2-DE and only human SOD1 was expressed in transgenic mice.
Wild-type Hemizygote
Hypothetical protein 
(Q99KP6)
2610008O03Rik protein 
(Q9D0K2)
Homozygote
4632432E04Rik protein
(Q9D358)
Mouse SOD1 Human SOD1Proteome Science 2004, 2 http://www.proteomesci.com/content/2/1/2
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dephosphorylate activated human platelet derived growth
factor BB (PDGF-BB) and insulin receptors, modulating
the onset of the mitogenic process [32]. LMW-PTP action
is exerted during the G1 phase of the cell cycle and affects
myc and fos gene transcription induced by PDGF-receptors
activation [33]. The enzyme also dephosphorylates EGF
receptors in bovine brain suggesting that it may be
involved in modulation of EGF signaling in the nerve tis-
sue [34]. In addition, the expression levels during neuro-
nal phenotype induction by nerve growth factor (NGF)
and during neurogenesis in chick embryos were investi-
gated [35]. These data indicate that the neurogenesis proc-
ess is accompanied by a physiological increment of LMW-
PTP expression in vitro and in vivo, using the developing
chick brain as experimental models [35].
Distribution of LMW-PTP in subcellular fractions of rat
brain tissue and the abundance of LMW-PTP in nerve end-
ings as well as in the cytosol suggest that this enzyme plays
an important role in synaptic function [36]. Despite the
relevant number of data reported on the structural and
catalytic features of a number of low Mr PTPases, only
limited information is presently available on the substrate
specificity and the true biological roles of these enzymes,
in prokaryotic, yeast and eukaryotic cells.
Hypothetical protein (Q99KP6) contains two conserved
domains: Ubox in the N-terminal region and WD-40
repeats in the C-terminal region (Fig. 3). Ubox, a modified
RING finger domain, was found in pre-mRNA splicing
factor, several hypothetical proteins, and ubiquitin fusion
Graphic view of putative conserved domains of hypothetical proteins Figure 3
Graphic view of putative conserved domains of hypothetical proteins. Domains were predicted by sequence-motif approach 
(Pfam, Pfam protein domain database, http://www.sanger.ac.uk/Pfam/) and NCBI database (BLAST search, http://
www.ncbi.nlm.nih.gov/BLAST).
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degradation protein 2, where it may be involved in E2-
dependent ubiquitination [37]. WD-repeat proteins are
characterized by weakly conserved core domain flanked
by the dipeptides GH and WD [38]. WD-repeats often
form a propeller structure that seems to be an ideal plat-
form for protein-protein interactions. Several cytoskeletal
proteins contain WD repeats and this structural motif also
occurs in the beta-subunit of heterotrimeric G proteins, a
component of the transmembrane signaling machinery
[39]. In addition, WD-40 domain was found in a number
of eukaryotic proteins that cover a wide variety of func-
tions including adaptor/regulatory modules in signal
transduction, pre-mRNA processing and cytoskeleton
assembly [38,40]. This HP was increased in SOD1-TG and
its over-expression may lead or represent impaired
cytoskeleton and/or mRNA splicing in hippocampus,
which in turn may be in agreement with cytoskeleton and
mRNA splicing deficits observed in DS brain [41,42].
Another major finding of this study is the demonstration
of human and mouse SOD1s in the same gel. This
allowed the concomitant quantification of these enzymes
from one and the same gel. The findings of absent human
SOD1 in the wild types, comparable expression in
hemizygous, and significantly higher levels in
homozygous SOD1-TGs biochemically and biologically
characterises and defines this mouse model. Moreover,
the fact that mouse SOD1 was significantly decreased in
hemizygous and homozygous SOD1-TGs may indicate
functionality and inclusion into the regulative system of
SOD1.
Conclusions
We herein provided a series of HPs that were predicted
from nucleic sequences only, to exist and expressed in
mouse hippocampus and the list of these proteins is con-
tributing by adding new structures to cascades and path-
ways. In addition, an analytical tool for the
characterisation of HPs in brain is given. Aberrant expres-
sion of some HPs may help to understand proteinchemi-
cal changes in the SOD1-TG hippocampus, which in turn
may allow insight into pathomechanisms of mental defi-
cits in the SOD1-TG per se but probably also in DS brain.
Methods
Mouse samples
Transgenic mice harbouring the human SOD1 gene were
obtained from Dr. Jacqueline London, University of Paris,
France. Generation of the human SOD1 transgenic line KT
has been described previously [43]; it has been obtained
by injecting an 11.5 kb EcoRI-BamH1 fragment contain-
ing the human SOD1 gene into fertilized eggs from FVB/
N mice. Fourteen to sixteen transgene copies were inserted
in tandem onto murine chromosome 15. Transgenic
progeny were identified by polymerase chain reaction
using DNA obtained from tail. Non-transgenic mice
(wild-type) were generated with normal FVB/N mice,
which were themselves initially obtained from crosses
between hemizygotes. Every effort was made to minimize
the number of animals used as well as to avoid any pain
and discomfort. Mice were sacrificed for the experiments
by decapitation and hippocampi was dissected by Rachel
Weitzdoerfer, MD, Univ. Vienna, Dpt of Neonatology and
Daniela Pollak, MSc, Univ. Vienna, Dpt of Basic Sciences
at -20°C and kept at -80°C until biochemical assays were
performed. The freezing chain was never interrupted until
use.
Measurement of SOD1 activity
For human SOD1 activity measurements, mice brain
extracts of WT and SOD1-TG mice were prepared in 100
mM Tris buffer, pH 7.5, with 0.1% (v/v) Tween 80. Activ-
ity of SOD1 was assayed photochemically by measuring
inhibition of nitroblue tetrazolium reduction using a Ran-
sod kit (Randox Laboratories) [44].
Two-dimensional gel electrophoresis (2-DE)
Hippocampal tissue was suspended in 1 ml of sample
buffer consisting of 40 mM Tris, 5 M urea (Merck, Darm-
stadt, Germany), 2 M thiourea (Sigma, St. Louis, MO,
USA), 4% CHAPS (3- [(3-cholamidopropyl) dimethylam-
monio]-1-propane-sulfonate) (Sigma), 10 mM 1,4-
dithioerythritol (Merck), and 1 mM EDTA (ethylenedi-
aminetetraacetic acid) (Merck), a mixture of protease
inhibitors, 1 mM phenylmethylsulfonyl chloride, and 1
µg of each pepstatin A, chymostatin, leupeptin, and
antipain. The suspension was sonicated for approximately
30 sec and centrifuged at 150,000 g for 45 min. The pro-
tein content in the supernatant was determined by the
Coomassie blue method [45]. 2-DE was performed essen-
tially as reported [41]. Samples of 0.7 mg protein were
applied on immobilized pH 3–10 non-linear gradient
strips in sample cups at their basic and acidic ends. Focus-
ing started at 200 V and the voltage was gradually
increased to 5000 V at 3 V/min and kept constant for a fur-
ther 24 h (approximately 180,000 Vh totally). The two-
dimensional separation was performed on 9–16% gradi-
ent sodium dodecyl sulfate polyacrylamide gels. The gels
(180 × 200 × 1.5 mm) were run at 40 mA per gel. After
protein fixation for 18 h in 50% methanol, containing 5%
acetic acid, the gels were stained with colloidal Coomassie
blue (Novex, San Diego, CA, USA) for 5 h. Molecular
masses were determined by running standard protein
markers (Gibco, Basel, Switzerland), covering the range
10–200 kDa. pI values were used as given by the supplier
of the immobilized pH gradient strips. Excess of dye was
washed out from the gels with distilled water and gels
were scanned in an Agfa DUOSCAN densitometer (reso-
lution 200). Electronic images of the gels were recordedProteome Science 2004, 2 http://www.proteomesci.com/content/2/1/2
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using Photoshop (Adobe) and PowerPoint (Microsoft)
software.
Matrix-assisted laser desorption/ionization mass 
spectrometry (MALDI-MS)
Spots were excised with spot picker (PROTEINEER sp™,
Bruker Daltonics, Germany), placed into 96-well micro-
titer plates and in-gel digestion and MALDI sample prep-
aration was performed by an automated procedure
(PROTEINEER dp™, Bruker Daltonics, Germany). Briefly,
spots were excised and washed seven times with 10 mM
ammonium bicarbonate and 50% acetonitrile in 10 mM
ammonium bicarbonate in turn. After washing, the gel
plugs were shrunk by addition of acetonitrile and dried by
blowing out the liquid through the pierced well bottom.
The dried gel pieces were reswollen with 40 ng/µl trypsin
(Roche Diagnostics, Germany) in enzyme buffer (consist-
ing of 5 mM Octyl β-D-glucopyranoside (OGP) and 10
mM ammonium bicarbonate) and incubated for 4 hrs at
30°C. Peptide extraction was performed with 10 µl of 1%
TFA in 5 mM OGP and directly applied onto a target
(AnchorChip™, Bruker Daltonics, Germany) that was
spotted with α-cyano-4-hydroxycinnamic acid (Sigma, St.
Louis, MO) matrix thinlayer. The mass spectrometer used
in this work was an Ultraflex™ TOF/TOF (Bruker Dalton-
ics, Germany) operated in the reflector mode. An acceler-
ating voltage of 25 kV was used. Calibration of the
instrument was performed externally with [M+H]+ ions of
angiotensin I, angiotensin II, substance P, bombesin, and
adrenocorticotropic hormones (clip 1–17 and clip 18–
39). Each spectrum was produced by accumulating data
from 50–200 consecutive laser shots. Spectra were inter-
preted with the aid of the Mascot Software (Matrix Science
Ltd, UK). For protein search, a mass tolerance of 100 ppm
and 2 missing cleavage sites were allowed and oxidation
of methionine residues was considered. The probability
score calculated by the software was used as criterion for
correct identification.
Quantification of protein spots
Protein spots were outlined (first automatically and then
manually) and quantified using the ImageMaster 2D Elite
software (Amersham Pharmacia Biotechnology). The per-
centage of the volume of the spots representing a certain
protein was determined in comparison with the total pro-
teins present in the 2-DE gel.
Statistical analysis
Protein levels are expressed as means ± standard deviation
of the percentage of the spot volume in each particular gel
after subtraction of the background values. Between-
group differences were analyzed using non-parametric
Mann-Whitney  U  test (for comparison between two
groups) and Kruskall-Wallis test (for comparison among
three groups). The level of significance was set at P < 0.05.
List of abbreviations used
2-DE, two-dimensional gel electrophoresis;
CHAPS, 3- [(3-cholamidopropyl) dimethylammonio]-1-
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MALDI-MS, matrix-assisted laser desorption ionization
mass spectrometry;
MS, mass spectrometry;
PTMs, post-translational modifications;
ROS, reactive oxygen species;
SOD1-TGs, transgenic mice overexpressing human Cu/
Zn-superoxide dismutase 1
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